Segall Bryant & Hamill’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Segall Bryant & Hamill’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-480,655	Closed	-$4.54M	–	515
2023 Q3	$4.54M	Sell	480,655 -3,352	-0.7%	-$40.3K	0.05%	335
2023 Q2	$6.76M	Buy	484,007 +2,438	+0.5%	+$41.6K	0.07%	298
2023 Q1	$9.03M	Buy	481,569 +93,041	+24%	+$1.53M	0.1%	243
2022 Q4	$5.35M	Buy	388,528 +26,970	+7%	+$413K	0.06%	312
2022 Q3	$6.91M	Buy	361,558 +97,545	+37%	+$1.78M	0.08%	262
2022 Q2	$4.03M	Buy	264,013 +78,288	+42%	+$1.16M	0.05%	353
2022 Q1	$3.78M	Buy	+185,725	New	+$3.78M	0.04%	371

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Segall Bryant & Hamill's CDMO Position: Q4 2023 in Review

Segall Bryant & Hamill sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 480,655 shares — an estimated $4.54M sold.

Segall Bryant & Hamill first reported a position in CDMO in Q1 2022 and held it in 7 quarters. The position peaked at $9.03M in Q1 2023. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

Segall Bryant & Hamill reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Segall Bryant & Hamill sold 480,655 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $4.54M.
Segall Bryant & Hamill first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Segall Bryant & Hamill's Avid Bioservices, Inc. Common Stock position peaked at $9.03M in Q1 2023.
174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Segall Bryant & Hamill's 13F filing for Q4 2023, filed 14 Feb 2024.